1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Wellcome Leap VISIBLE Program for AI and Machine Learning Diagnosis of Coronary Microvascular Disease in Women" is currently closed and not accepting applications.
VISIBLE is a $55 million Wellcome Leap program co-funded with Pivotal Ventures and the British Heart Foundation that aims to increase the proportion of women presenting with stable angina who receive effective diagnosis and treatment for coronary microvascular disease (CMD) from less than 1 percent to more than 80 percent.
The program explicitly funds artificial intelligence and machine learning approaches that identify signatures of CMD from data already acquired in routine clinical care (ECGs, echocardiograms, cardiac MRI, blood-based biomarkers, electronic health records, wearable signals), develop multimodal diagnostic models that integrate imaging and physiologic data, and validate them in prospective and retrospective cohorts.
Funded teams must propose scalable, deployable diagnostic systems and demonstrate measurable improvement in CMD detection over current standard of care.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities, research institutions, small, medium, and large companies, government agencies, and non-profit organizations from any legal jurisdiction worldwide. Multidisciplinary teams spanning cardiology, AI/ML, biomedical informatics, and clinical operations are expected. Full execution of Wellcome Leap MARFA required prior to any award. Confirm the full requirements in the official notice before applying.
The current listing shows $55 million total program budget across multiple performer teams. Individual award amounts are not publicly fixed but Wellcome Leap typical performer awards range from $1 million to $5 million USD per team over the program lifetime, with milestone-driven extensions. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 23, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Wellcome Leap VISIBLE Program for AI and Machine Learning Diagnosis of Coronary Microvascular Disease in Women is funded by Wellcome Leap with Pivotal Ventures and British Heart Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
MacKenzie Scott's Yield Giving has moved more than $26 billion — including roughly $7 billion in 2025, over a third of all U.S. megagifts — through unrestricted, trust-based grants with no application. Melinda French Gates's Pivotal Ventures has committed $2 billion to women's health and economic power. The Bezos philanthropies have moved billions more. As the Buffett–Gates era winds down, this new class of megadonor is rewriting the rules of major giving. Here is what changes for nonprofits, and how to become the kind of organization this money finds.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleAt CGI on September 23, 2026, Global Impact Ventures committed $100 million over three years across economic opportunity, health, education, climate resilience and humanitarian needs. There is no application portal. The access route is the intermediary infrastructure — fiscal sponsorship, grantmaking administration, and a 250-organization network.
Read article